CORONARY INTERVENTIONS
One-year outcomes in unselected patients treated with a thin-strut, platinum-chromium, paclitaxel-eluting stent: primary endpoint results from the TAXUS Element European post-approval surveillance study (TE-PROVE)
Tamburino C, Capodanno D, Erglis A, Menown I, Horvath I, Moreno R, Gilbert T, Crowley J, Calabria P, Allocco DJ, Dawkins K
10.4244/EIJY15M01_01
free
One-year outcomes in 1,010 unselected patients treated with the PROMUS Element everolimus-eluting stent: the multicentre PROMUS Element European Post-Approval Surveillance Study
Thomas M, Birkemeyer R, Schwimmbeck P, Legrand V, Moreno R, Briguori C, Werner N, Bramucci E, Ungi I, Richardt G, Underwood P, Dawkins K
10.4244/EIJY15M01_07
free
Safety of second-generation drug-eluting stents three years after randomised use in the TWENTE trial
Löwik M, Lam MK, Sen H, Tandjung K, van Houwelingen K, de Man F, Stoel M, Louwerenburg H, Linssen GCM, Doggen CJM, von Birgelen C
10.4244/EIJY14M08_11
free
Five-year results of a randomised comparison of titanium-nitride-oxide-coated stents with zotarolimus-eluting stents for coronary revascularisation
Pilgrim T, Räber L, Limacher A, Wenaweser P, Cook S, Stauffer J-C, Garachemani A, Moschovitis A, Meier B, Jüni P, Windecker S
10.4244/EIJY15M01_04
free
Circumferential distribution of the neointima at six-month and two-year follow-up after a bioresorbable vascular scaffold implantation: a substudy of the ABSORB Cohort B Clinical Trial
Bourantas C, Farooq V, Zhang Y-J, Muramatsu T, Gogas B, Thuesen L, McClean D, Chevalier B, Windecker S, Koolen J, Ormiston J, Whitbourn R, Dorange C, Rapoza R, Onuma Y, Garcia-Garcia H, Serruys PW
10.4244/EIJY14M04_11
free
A novel homemade snare, safe, economical and size-adjustable
Yokoi K, Sumitsuji S, Kaneda H, Siegrist P, Okayama K, Ide S, Mizote I, Kumada M, Kuroda T, Tachibana K, Sakata Y, Nanto S
10.4244/EIJV10I11A220
free
Optical coherence tomography appraisal of residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing intraprocedural versus post-stenting prolonged bivalirudin infusion. Rationale and design of the MATRIX (Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and angioX) OCT substudy
Picci A, Limbruno U, Andò G, Brugaletta S, Cortese B, De Carlo M, Garcia-Garcia H, Palmieri C, Regar E, Rigattieri S, Sardella G, Zimarino M, Valgimigli M
10.4244/EIJY15M02_10
free
A Y-shaped bifurcation-dedicated stent for the treatment of de novo coronary bifurcation lesions: an IVUS analysis from the BRANCH trial
Sakata K, Koo B, Waseda K, Nakatani D, Yock P, Whitbourn R, Worthley S, Ormiston J, Webster M, Wilkins G, Honda Y, Meredith I, Fitzgerald P
10.4244/EIJY14M08_16
free
INTERVENTIONS FOR STRUCTURAL HEART DISEASE
TRINITY heart valve prosthesis: a novel repositionable and retrievable transapical transcatheter aortic valve system
Hengstenberg C, Condado J, García D, Martinez M, La Forgia G, Ebner A, Gallo S, Silva E, Holzamer A, Husser O, Hilker M
10.4244/EIJY14M07_08
free
Percutaneous complete repair of failed mitral valve prosthesis: simultaneous closure of mitral paravalvular leaks and transcatheter mitral valve implantation – single-centre experience
Kliger C, Angulo R, Maranan L, Kumar R, Jelnin V, Kronzon I, Fontana G, Plestis K, Patel N, Perk G, Ruiz C
10.4244/EIJY14M05_01
free
The MITRA-FR study: design and rationale of a randomised study of percutaneous mitral valve repair compared with optimal medical management alone for severe secondary mitral regurgitation
Obadia J, Armoiry X, Iung B, Lefèvre T, Mewton N, Messika-Zeitoun D, Cormier B, Berthiller J, Maucort-Boulch D, Boutitie F, Vaz B, Trochu J, Vahanian A
10.4244/EIJV10I11A232
free
